rs1036199

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_032782.5(HAVCR2):​c.419G>T​(p.Arg140Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.834 in 1,600,776 control chromosomes in the GnomAD database, including 558,802 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R140W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.83 ( 53089 hom., cov: 33)
Exomes 𝑓: 0.83 ( 505713 hom. )

Consequence

HAVCR2
NM_032782.5 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.202

Publications

73 publications found
Variant links:
Genes affected
HAVCR2 (HGNC:18437): (hepatitis A virus cellular receptor 2) The protein encoded by this gene belongs to the immunoglobulin superfamily, and TIM family of proteins. CD4-positive T helper lymphocytes can be divided into types 1 (Th1) and 2 (Th2) on the basis of their cytokine secretion patterns. Th1 cells are involved in cell-mediated immunity to intracellular pathogens and delayed-type hypersensitivity reactions, whereas, Th2 cells are involved in the control of extracellular helminthic infections and the promotion of atopic and allergic diseases. This protein is a Th1-specific cell surface protein that regulates macrophage activation, and inhibits Th1-mediated auto- and alloimmune responses, and promotes immunological tolerance. [provided by RefSeq, Sep 2011]
HAVCR2 Gene-Disease associations (from GenCC):
  • subcutaneous panniculitis-like T-cell lymphoma
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=8.7537273E-7).
BP6
Variant 5-157104725-C-A is Benign according to our data. Variant chr5-157104725-C-A is described in ClinVar as Benign. ClinVar VariationId is 1285330.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.964 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HAVCR2NM_032782.5 linkc.419G>T p.Arg140Leu missense_variant Exon 3 of 7 ENST00000307851.9 NP_116171.3 Q8TDQ0-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HAVCR2ENST00000307851.9 linkc.419G>T p.Arg140Leu missense_variant Exon 3 of 7 1 NM_032782.5 ENSP00000312002.4 Q8TDQ0-1

Frequencies

GnomAD3 genomes
AF:
0.834
AC:
126877
AN:
152096
Hom.:
53052
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.802
Gnomad AMI
AF:
0.898
Gnomad AMR
AF:
0.887
Gnomad ASJ
AF:
0.888
Gnomad EAS
AF:
0.987
Gnomad SAS
AF:
0.952
Gnomad FIN
AF:
0.853
Gnomad MID
AF:
0.823
Gnomad NFE
AF:
0.816
Gnomad OTH
AF:
0.838
GnomAD2 exomes
AF:
0.865
AC:
203321
AN:
234978
AF XY:
0.868
show subpopulations
Gnomad AFR exome
AF:
0.806
Gnomad AMR exome
AF:
0.924
Gnomad ASJ exome
AF:
0.883
Gnomad EAS exome
AF:
0.989
Gnomad FIN exome
AF:
0.839
Gnomad NFE exome
AF:
0.815
Gnomad OTH exome
AF:
0.850
GnomAD4 exome
AF:
0.834
AC:
1208317
AN:
1448562
Hom.:
505713
Cov.:
34
AF XY:
0.837
AC XY:
602396
AN XY:
719370
show subpopulations
African (AFR)
AF:
0.802
AC:
26731
AN:
33318
American (AMR)
AF:
0.919
AC:
39888
AN:
43404
Ashkenazi Jewish (ASJ)
AF:
0.883
AC:
22680
AN:
25682
East Asian (EAS)
AF:
0.983
AC:
38898
AN:
39588
South Asian (SAS)
AF:
0.951
AC:
79997
AN:
84162
European-Finnish (FIN)
AF:
0.838
AC:
44145
AN:
52696
Middle Eastern (MID)
AF:
0.833
AC:
4774
AN:
5730
European-Non Finnish (NFE)
AF:
0.816
AC:
900587
AN:
1104120
Other (OTH)
AF:
0.846
AC:
50617
AN:
59862
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.456
Heterozygous variant carriers
0
8980
17960
26941
35921
44901
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20912
41824
62736
83648
104560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.834
AC:
126972
AN:
152214
Hom.:
53089
Cov.:
33
AF XY:
0.840
AC XY:
62552
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.801
AC:
33268
AN:
41516
American (AMR)
AF:
0.887
AC:
13562
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.888
AC:
3079
AN:
3468
East Asian (EAS)
AF:
0.987
AC:
5117
AN:
5184
South Asian (SAS)
AF:
0.952
AC:
4597
AN:
4828
European-Finnish (FIN)
AF:
0.853
AC:
9048
AN:
10604
Middle Eastern (MID)
AF:
0.827
AC:
243
AN:
294
European-Non Finnish (NFE)
AF:
0.816
AC:
55468
AN:
68012
Other (OTH)
AF:
0.840
AC:
1771
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1069
2138
3208
4277
5346
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
890
1780
2670
3560
4450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.827
Hom.:
229843
Bravo
AF:
0.836
TwinsUK
AF:
0.818
AC:
3034
ALSPAC
AF:
0.814
AC:
3136
ESP6500AA
AF:
0.811
AC:
3573
ESP6500EA
AF:
0.813
AC:
6994
ExAC
AF:
0.857
AC:
103696
Asia WGS
AF:
0.955
AC:
3321
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Subcutaneous panniculitis-like T-cell lymphoma Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 99% of patients studied by a panel of primary immunodeficiencies. Number of patients: 94. Only high quality variants are reported. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.065
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
3.9
DANN
Benign
0.68
DEOGEN2
Benign
0.0016
T;.
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.0044
N
LIST_S2
Benign
0.20
T;T
MetaRNN
Benign
8.8e-7
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-1.7
N;.
PhyloP100
0.20
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-0.030
N;N
REVEL
Benign
0.019
Sift
Benign
0.47
T;T
Sift4G
Benign
0.37
T;.
Polyphen
0.0
B;.
Vest4
0.015
MPC
0.16
ClinPred
0.0017
T
GERP RS
-0.064
Varity_R
0.040
gMVP
0.26
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1036199; hg19: chr5-156531736; COSMIC: COSV107332215; COSMIC: COSV107332215; API